keyword
https://read.qxmd.com/read/37733172/correction-to-decreased-local-specialization-of-brain-structural-networks-associated-with-cognitive-dysfuntion-revealed-by-probabilistic-diffusion-tractography-for-different-cerebral-small-vessel-disease-burdens
#1
Mengmeng Feng, Hongwei Wen, Haotian Xin, Shengpei Wang, Yian Gao, Chaofan Sui, Changhu Liang, Lingfei Guo
No abstract text is available yet for this article.
September 21, 2023: Molecular Neurobiology
https://read.qxmd.com/read/37606718/decreased-local-specialization-of-brain-structural-networks-associated-with-cognitive-dysfuntion-revealed-by-probabilistic-diffusion-tractography-for-different-cerebral-small-vessel-disease-burdens
#2
JOURNAL ARTICLE
Mengmeng Feng, Hongwei Wen, Haotian Xin, Shengpei Wang, Yian Gao, Chaofan Sui, Changhu Liang, Lingfei Guo
There are differences in brain structural networks in different CSVD burdens. The structural networks were constructed by probabilistic diffusion tractography, and the topological properties were characterized using graph theory. The network efficiencies were significantly decreased in the CSVD-s group. The decreased network efficiencies were correlated with cognitive function.
August 22, 2023: Molecular Neurobiology
https://read.qxmd.com/read/33927145/perceived-discrimination-and-symptoms-of-cognitive-dysfuntion-among-middle-age-and-older-persons-living-with-hiv-in-china-a-multicenter-cross-sectional-study-of-the-mediating-role-of-mental-health-symptoms-and-social-isolation
#3
JOURNAL ARTICLE
Shuyu Han, Yan Hu, Lina Wang, Yaolin Pei, Zheng Zhu, Xiang Qi, Zheng Zhu, Xiang Qi, Bei Wu
Perceived discrimination is associated with symptoms of cognitive dysfunction (SOCD) among middle-age and older persons living with HIV (PLWH). We aimed to explore how the association between perceived discrimination and SOCD was mediated by mental health symptoms and social isolation. The sample included 321 PLWH, ages 45 years and older, for a multicenter cross-sectional study. Structural equation modeling showed an acceptable model fit and a significant total indirect effect between perceived discrimination and SOCD...
April 28, 2021: Journal of the Association of Nurses in AIDS Care: JANAC
https://read.qxmd.com/read/30933046/corpus-callosum-metrics-predict-severity-of-visuospatial-and-neuromotor-dysfunctions-in-arid1b-mutations-with-coffin-siris-syndrome
#4
JOURNAL ARTICLE
Caroline Demily, Charlyne Duwime, Clémence Lopez, Cherhazad Hemimou, Alice Poisson, Julien Plasse, Matthieu P Robert, Charlotte Dénier, Massimiliano Rossi, Nicolas Franck, Claude Besmond, Giulia Barcia, Nathalie Boddaert, Arnold Munnich, Laurence Vaivre-Douret
ARID1B mutations in Coffin-Siris syndrome are a cause of intellectual disability (0.5-1%), with various degrees of autism and agenesis of the corpus callosum (10%). Little is known regarding the cognitive and motor consequences of ARID1B mutations in humans and no link has been made between corpus callosum anomalies and visuospatial and neuromotor dysfunctions. We have investigated the visuospatial and neuromotor phenotype in eight patients with ARID1B mutations. A paramedian sagittal section of the brain MRI was selected, and corpus callosum was measured in anteroposterior length, genu and trunk width...
December 2019: Psychiatric Genetics
https://read.qxmd.com/read/24325271/7-8-dihydroxyflavone-ameliorates-scopolamine-induced-alzheimer-like-pathologic-dysfunction
#5
JOURNAL ARTICLE
Chong Chen, Xiao-Hong Li, Sai Zhang, Yue Tu, Yan-Min Wang, Hong-Tao Sun
Scopolamine (Sco) can induce amyloid β (Aβ) deposition, oxidative stress, synaptic dysfunction, and learning/memory impairment as observed in Alzheimer's disease (AD), the most common form of dementia affecting more than 25 million elderly people worldwide. Herein we explored the protective effect of 7,8-dihydroxyflavone (7,8-DHF) on Sco-induced Aβ deposition, oxidative stress, synaptic dysfunction, and learning/memory defects. Rats were randomly divided into four groups (n=12 for each group). The control group received normal saline (NS); the Sco group received Sco (1 mg/kg per day) intraperitoneally (i...
June 2014: Rejuvenation Research
https://read.qxmd.com/read/18214210/-chronic-fatigue-syndrome-a-functional-somatic-syndrome
#6
REVIEW
Andreas Linde
Chronic fatigue can be categorized as a functional somatic syndrome (fss), because there are findings of typical preconditions, trigger mechanisms and maintaining conditions. With relevance for therapy it makes sense to see it as an medical-psychiatric interface-disorder Subsyndromal short episodes of chronic fatigue are many more frequent as three or six month during clearly diagnosed episodes of "neurasthenia" or "chronic fatigue syndrome". Their descriptions are very similar and obvious those means the same matter...
October 2007: Therapeutische Umschau. Revue Thérapeutique
https://read.qxmd.com/read/17404779/effect-of-exogenous-melatonin-on-sleep-and-motor-dysfunction-in-parkinson-s-disease-a-randomized-double-blind-placebo-controlled-study
#7
RANDOMIZED CONTROLLED TRIAL
Camila Andrade Mendes Medeiros, Pedro Felipe Carvalhedo de Bruin, Lívia Ariane Lopes, Maria Cecília Magalhães, Maria de Lourdes Seabra, Veralice Meireles Sales de Bruin
Insomnia, sleep fragmentation and excessive daytime sleepiness are common in Parkinson's disease (PD) and may contribute to the reduction of cognition and alertness in those patients. Melatonin has been shown to improve sleep in several conditions. In experimental models of PD, melatonin can ameliorate motor symptoms. To evaluate the effect of melatonin on sleep and motor dysfuntion in PD, we studied 18 patients (Hoehn & Yahr I to III) from a PD clinic. Prior to treatment, motor dysfunction was assessed by UPDRS II, III and IV...
April 2007: Journal of Neurology
https://read.qxmd.com/read/11738011/-effectiveness-of-donepezil-on-several-cognitive-functions-in-patients-with-alzheimer-s-disease-over-12-months
#8
JOURNAL ARTICLE
S López-Pousa, J Vilalta-Franch, J Garre-Olmo, A Turon-Estrada, M Lozano-Gallego, M Hernàndez-Ferràndiz, C Fajardo-Tibau, M M Cruz-Reina
OBJECTIVES: The efficacy of donepezil for the treatment of cognitive dysfuntion in Alzheimer's disease has been demonstrated. The objective [corrected] of this study was to evaluate the effectiveness of donepezil in different neuropsychological areas of mild or moderate AD patients over a period of twelve months compared with data from untreated patients (historical control). METHODS: This was an open-label study where 100 patients received donepezil 5mg or 10 mg/day for twelve months...
October 2001: Neurología: Publicación Oficial de la Sociedad Española de Neurología
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.